{"count":221304,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1115","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1113","results":[{"created":"2021-11-28T17:37:57.705233+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.754","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CYP21A2 were changed from Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency; Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency to Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, MIM# 201910","entity_name":"CYP21A2","entity_type":"gene"},{"created":"2021-11-28T17:37:41.340473+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.753","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CYP21A2: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, MIM# 201910; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYP21A2","entity_type":"gene"},{"created":"2021-11-28T17:36:28.450999+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.753","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CYP1B1 as ready","entity_name":"CYP1B1","entity_type":"gene"},{"created":"2021-11-28T17:36:28.438835+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.753","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cyp1b1 has been classified as Green List (High Evidence).","entity_name":"CYP1B1","entity_type":"gene"},{"created":"2021-11-28T17:36:25.060063+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.753","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CYP1B1 were changed from PRIMARY CONGENITAL GLAUCOMA TYPE 3A to Anterior segment dysgenesis 6, multiple subtypes, MIM# 617315; Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset, MIM# 231300","entity_name":"CYP1B1","entity_type":"gene"},{"created":"2021-11-28T17:36:12.911090+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.752","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYP1B1 were set to ","entity_name":"CYP1B1","entity_type":"gene"},{"created":"2021-11-28T17:36:01.401551+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.751","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CYP1B1 was changed from BIALLELIC, autosomal or pseudoautosomal to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"CYP1B1","entity_type":"gene"},{"created":"2021-11-28T17:35:45.353841+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.750","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CYP1B1: Rating: GREEN; Mode of pathogenicity: None; Publications: 32499604, 32224865; Phenotypes: Anterior segment dysgenesis 6, multiple subtypes, MIM# 617315, Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset, MIM# 231300; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"CYP1B1","entity_type":"gene"},{"created":"2021-11-28T17:32:19.750978+11:00","panel_name":"Differences of Sex Development","panel_id":99,"panel_version":"0.232","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CYP17A1 as ready","entity_name":"CYP17A1","entity_type":"gene"},{"created":"2021-11-28T17:32:19.733594+11:00","panel_name":"Differences of Sex Development","panel_id":99,"panel_version":"0.232","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cyp17a1 has been classified as Green List (High Evidence).","entity_name":"CYP17A1","entity_type":"gene"},{"created":"2021-11-28T17:32:17.504032+11:00","panel_name":"Differences of Sex Development","panel_id":99,"panel_version":"0.232","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CYP17A1 were changed from  to 17-alpha-hydroxylase/17,20-lyase deficiency, MIM# 202110","entity_name":"CYP17A1","entity_type":"gene"},{"created":"2021-11-28T17:31:54.921364+11:00","panel_name":"Differences of Sex Development","panel_id":99,"panel_version":"0.231","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYP17A1 were set to ","entity_name":"CYP17A1","entity_type":"gene"},{"created":"2021-11-28T17:31:26.346764+11:00","panel_name":"Differences of Sex Development","panel_id":99,"panel_version":"0.230","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CYP17A1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYP17A1","entity_type":"gene"},{"created":"2021-11-28T17:31:02.099920+11:00","panel_name":"Differences of Sex Development","panel_id":99,"panel_version":"0.229","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CYP17A1: Rating: GREEN; Mode of pathogenicity: None; Publications: 2843762, 14671162, 2026124; Phenotypes: 17-alpha-hydroxylase/17,20-lyase deficiency, MIM# 202110; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYP17A1","entity_type":"gene"},{"created":"2021-11-28T17:30:27.554881+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9915","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CYP17A1 as ready","entity_name":"CYP17A1","entity_type":"gene"},{"created":"2021-11-28T17:30:27.544341+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9915","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cyp17a1 has been classified as Green List (High Evidence).","entity_name":"CYP17A1","entity_type":"gene"},{"created":"2021-11-28T17:30:21.166408+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9915","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CYP17A1 were changed from  to 17-alpha-hydroxylase/17,20-lyase deficiency, MIM# 202110","entity_name":"CYP17A1","entity_type":"gene"},{"created":"2021-11-28T17:30:04.654014+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9914","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYP17A1 were set to ","entity_name":"CYP17A1","entity_type":"gene"},{"created":"2021-11-28T17:29:45.996856+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9913","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CYP17A1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYP17A1","entity_type":"gene"},{"created":"2021-11-28T17:29:30.261266+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9912","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CYP17A1: Rating: GREEN; Mode of pathogenicity: None; Publications: 2843762, 14671162, 2026124; Phenotypes: 17-alpha-hydroxylase/17,20-lyase deficiency, MIM# 202110; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYP17A1","entity_type":"gene"},{"created":"2021-11-28T17:28:37.015860+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.750","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CYP17A1 as ready","entity_name":"CYP17A1","entity_type":"gene"},{"created":"2021-11-28T17:28:37.006474+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.750","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cyp17a1 has been classified as Green List (High Evidence).","entity_name":"CYP17A1","entity_type":"gene"},{"created":"2021-11-28T17:28:32.309647+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.750","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CYP17A1 were changed from 17-alpha-hydroxylase/17,20-lyase deficiency; 17,20-lyase deficiency, isolated to 17-alpha-hydroxylase/17,20-lyase deficiency, MIM# 202110","entity_name":"CYP17A1","entity_type":"gene"},{"created":"2021-11-28T17:28:17.684040+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.749","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYP17A1 were set to ","entity_name":"CYP17A1","entity_type":"gene"},{"created":"2021-11-28T17:28:02.775170+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.748","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CYP17A1: Rating: GREEN; Mode of pathogenicity: None; Publications: 2843762, 14671162, 2026124; Phenotypes: 17-alpha-hydroxylase/17,20-lyase deficiency, MIM# 202110; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYP17A1","entity_type":"gene"},{"created":"2021-11-28T17:25:43.475430+11:00","panel_name":"Differences of Sex Development","panel_id":99,"panel_version":"0.229","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CYP11B1 as ready","entity_name":"CYP11B1","entity_type":"gene"},{"created":"2021-11-28T17:25:43.460612+11:00","panel_name":"Differences of Sex Development","panel_id":99,"panel_version":"0.229","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cyp11b1 has been classified as Green List (High Evidence).","entity_name":"CYP11B1","entity_type":"gene"},{"created":"2021-11-28T17:25:41.171141+11:00","panel_name":"Differences of Sex Development","panel_id":99,"panel_version":"0.229","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CYP11B1 were changed from  to Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, MIM# 202010","entity_name":"CYP11B1","entity_type":"gene"},{"created":"2021-11-28T17:25:17.303395+11:00","panel_name":"Differences of Sex Development","panel_id":99,"panel_version":"0.228","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYP11B1 were set to ","entity_name":"CYP11B1","entity_type":"gene"},{"created":"2021-11-28T17:24:54.494323+11:00","panel_name":"Differences of Sex Development","panel_id":99,"panel_version":"0.227","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CYP11B1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYP11B1","entity_type":"gene"},{"created":"2021-11-28T17:24:23.453515+11:00","panel_name":"Differences of Sex Development","panel_id":99,"panel_version":"0.226","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CYP11B1: Rating: GREEN; Mode of pathogenicity: None; Publications: 8768848; Phenotypes: Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, MIM# 202010; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYP11B1","entity_type":"gene"},{"created":"2021-11-28T17:23:40.623044+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9912","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CYP11B1 as ready","entity_name":"CYP11B1","entity_type":"gene"},{"created":"2021-11-28T17:23:40.613722+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9912","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cyp11b1 has been classified as Green List (High Evidence).","entity_name":"CYP11B1","entity_type":"gene"},{"created":"2021-11-28T17:23:33.446412+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9912","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CYP11B1 were changed from  to Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, MIM# 202010; Aldosteronism, glucocorticoid-remediable, MIM# 103900","entity_name":"CYP11B1","entity_type":"gene"},{"created":"2021-11-28T17:23:14.857320+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9911","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYP11B1 were set to ","entity_name":"CYP11B1","entity_type":"gene"},{"created":"2021-11-28T17:22:55.486846+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9910","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CYP11B1 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"CYP11B1","entity_type":"gene"},{"created":"2021-11-28T17:22:35.726381+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9909","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CYP11B1: Rating: GREEN; Mode of pathogenicity: None; Publications: 8768848, 1731223, 29703198; Phenotypes: Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, MIM# 202010, Aldosteronism, glucocorticoid-remediable, MIM# 103900; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"CYP11B1","entity_type":"gene"},{"created":"2021-11-28T17:20:02.188454+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.748","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CYP11B1 as ready","entity_name":"CYP11B1","entity_type":"gene"},{"created":"2021-11-28T17:20:02.168649+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.748","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cyp11b1 has been classified as Green List (High Evidence).","entity_name":"CYP11B1","entity_type":"gene"},{"created":"2021-11-28T17:19:58.625214+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.748","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CYP11B1 were changed from Aldosteronism, glucocorticoid-remediable 103900; Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency 202010 to Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, MIM# 202010","entity_name":"CYP11B1","entity_type":"gene"},{"created":"2021-11-28T17:19:46.383299+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.747","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYP11B1 were set to ","entity_name":"CYP11B1","entity_type":"gene"},{"created":"2021-11-28T17:19:36.479073+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.746","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CYP11B1 was changed from BOTH monoallelic and biallelic, autosomal or pseudoautosomal to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYP11B1","entity_type":"gene"},{"created":"2021-11-28T17:19:21.662097+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.745","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CYP11B1: Rating: GREEN; Mode of pathogenicity: None; Publications: 8768848; Phenotypes: Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, MIM# 202010; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYP11B1","entity_type":"gene"},{"created":"2021-11-28T17:15:52.874220+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.342","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CYP11A1 as ready","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:15:52.863313+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.342","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cyp11a1 has been classified as Red List (Low Evidence).","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:15:49.536812+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.342","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CYP11A1 were changed from  to Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, MIM# 613743","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:15:19.513655+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.341","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYP11A1 were set to ","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:14:50.946852+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.340","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CYP11A1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:14:28.369439+11:00","panel_name":"Differences of Sex Development","panel_id":99,"panel_version":"0.226","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CYP11A1 as ready","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:14:28.359113+11:00","panel_name":"Differences of Sex Development","panel_id":99,"panel_version":"0.226","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cyp11a1 has been classified as Green List (High Evidence).","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:14:27.276969+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.339","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CYP11A1 as Red List (low evidence)","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:14:27.267441+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.339","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cyp11a1 has been classified as Red List (Low Evidence).","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:14:01.053554+11:00","panel_name":"Differences of Sex Development","panel_id":99,"panel_version":"0.226","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CYP11A1 were changed from  to Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, MIM# 613743","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:13:56.472000+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.338","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CYP11A1: Rating: RED; Mode of pathogenicity: None; Publications: 12161514, 16705068, 18182448, 28425981; Phenotypes: Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, MIM# 613743; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:13:31.823441+11:00","panel_name":"Differences of Sex Development","panel_id":99,"panel_version":"0.225","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYP11A1 were set to ","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:13:08.480123+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9909","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CYP11A1 as ready","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:13:08.468200+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9909","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cyp11a1 has been classified as Green List (High Evidence).","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:12:57.867005+11:00","panel_name":"Differences of Sex Development","panel_id":99,"panel_version":"0.224","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CYP11A1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:12:29.450377+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9909","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CYP11A1 were changed from  to Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, MIM# 613743","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:12:27.453849+11:00","panel_name":"Differences of Sex Development","panel_id":99,"panel_version":"0.223","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CYP11A1: Rating: GREEN; Mode of pathogenicity: None; Publications: 12161514, 16705068, 18182448, 28425981; Phenotypes: Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, MIM# 613743; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:12:12.266438+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9908","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYP11A1 were set to ","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:11:40.101049+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9907","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CYP11A1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:11:16.656364+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9906","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CYP11A1: Rating: GREEN; Mode of pathogenicity: None; Publications: 12161514, 16705068, 18182448, 28425981; Phenotypes: Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, MIM# 613743; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:10:30.628594+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.745","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: CYP11A1: Changed publications: 12161514, 16705068, 18182448, 28425981","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:10:17.649244+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.745","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CYP11A1 as ready","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:10:17.638892+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.745","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cyp11a1 has been classified as Green List (High Evidence).","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:10:02.101399+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.745","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CYP11A1 were changed from Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete 613743 to Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, MIM# 613743","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:09:49.837576+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.744","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYP11A1 were set to 28425981","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:09:34.579183+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.743","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CYP11A1: Rating: GREEN; Mode of pathogenicity: None; Publications: 12161514, 16705068, 18182448; Phenotypes: Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, MIM# 613743; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CYP11A1","entity_type":"gene"},{"created":"2021-11-28T17:06:46.692756+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4316","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CWC27 as ready","entity_name":"CWC27","entity_type":"gene"},{"created":"2021-11-28T17:06:46.680860+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4316","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cwc27 has been classified as Green List (High Evidence).","entity_name":"CWC27","entity_type":"gene"},{"created":"2021-11-28T17:06:43.097206+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4316","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CWC27 were changed from  to Retinitis pigmentosa with or without skeletal anomalies, MIM# 250410","entity_name":"CWC27","entity_type":"gene"},{"created":"2021-11-28T17:06:09.901159+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4315","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CWC27 were set to ","entity_name":"CWC27","entity_type":"gene"},{"created":"2021-11-28T17:05:39.229751+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4314","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CWC27 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CWC27","entity_type":"gene"},{"created":"2021-11-28T17:05:12.653788+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4313","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CWC27: Rating: GREEN; Mode of pathogenicity: None; Publications: 28285769, 31481716; Phenotypes: Retinitis pigmentosa with or without skeletal anomalies, MIM# 250410; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CWC27","entity_type":"gene"},{"created":"2021-11-28T17:04:41.183276+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9906","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CWC27 as ready","entity_name":"CWC27","entity_type":"gene"},{"created":"2021-11-28T17:04:41.172797+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9906","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cwc27 has been classified as Green List (High Evidence).","entity_name":"CWC27","entity_type":"gene"},{"created":"2021-11-28T17:04:33.677267+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9906","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CWC27 were changed from  to Retinitis pigmentosa with or without skeletal anomalies, MIM# 250410","entity_name":"CWC27","entity_type":"gene"},{"created":"2021-11-28T17:04:15.342637+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9905","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CWC27 were set to ","entity_name":"CWC27","entity_type":"gene"},{"created":"2021-11-28T17:03:58.408031+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9904","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CWC27 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CWC27","entity_type":"gene"},{"created":"2021-11-28T17:03:40.970021+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9903","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CWC27: Rating: GREEN; Mode of pathogenicity: None; Publications: 28285769, 31481716; Phenotypes: Retinitis pigmentosa with or without skeletal anomalies, MIM# 250410; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CWC27","entity_type":"gene"},{"created":"2021-11-28T17:03:04.870774+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.743","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CWC27 as ready","entity_name":"CWC27","entity_type":"gene"},{"created":"2021-11-28T17:03:04.859884+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.743","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cwc27 has been classified as Green List (High Evidence).","entity_name":"CWC27","entity_type":"gene"},{"created":"2021-11-28T17:03:00.773904+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.743","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CWC27 were changed from Retinitis pigmentosa, skeletal anomalies and intellectual disability to Retinitis pigmentosa with or without skeletal anomalies, MIM# 250410","entity_name":"CWC27","entity_type":"gene"},{"created":"2021-11-28T17:02:47.954748+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.742","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CWC27 were set to 28285769","entity_name":"CWC27","entity_type":"gene"},{"created":"2021-11-28T17:02:33.231917+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.741","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CWC27: Rating: GREEN; Mode of pathogenicity: None; Publications: 28285769, 31481716; Phenotypes: Retinitis pigmentosa with or without skeletal anomalies, MIM# 250410; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CWC27","entity_type":"gene"},{"created":"2021-11-28T16:56:53.418204+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.741","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CUL7 as ready","entity_name":"CUL7","entity_type":"gene"},{"created":"2021-11-28T16:56:53.408155+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.741","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cul7 has been classified as Green List (High Evidence).","entity_name":"CUL7","entity_type":"gene"},{"created":"2021-11-28T16:56:49.876352+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.741","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CUL7 were changed from 3-M SYNDROME 1 to 3-M syndrome 1, MIM# 273750; Yakut short stature syndrome","entity_name":"CUL7","entity_type":"gene"},{"created":"2021-11-28T16:56:38.423706+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.740","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CUL7 were set to ","entity_name":"CUL7","entity_type":"gene"},{"created":"2021-11-28T16:56:23.696020+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.739","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CUL7: Rating: GREEN; Mode of pathogenicity: None; Publications: 16142236, 19225462, 17675530; Phenotypes: 3-M syndrome 1, MIM# 273750, Yakut short stature syndrome; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CUL7","entity_type":"gene"},{"created":"2021-11-26T20:07:17.994827+11:00","panel_name":"Osteogenesis Imperfecta","panel_id":147,"panel_version":"0.71","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PPIB as ready","entity_name":"PPIB","entity_type":"gene"},{"created":"2021-11-26T20:07:17.984176+11:00","panel_name":"Osteogenesis Imperfecta","panel_id":147,"panel_version":"0.71","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ppib has been classified as Green List (High Evidence).","entity_name":"PPIB","entity_type":"gene"},{"created":"2021-11-26T20:07:15.594971+11:00","panel_name":"Osteogenesis Imperfecta","panel_id":147,"panel_version":"0.71","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PPIB were changed from  to Osteogenesis imperfecta, type IX, MIM# 259440","entity_name":"PPIB","entity_type":"gene"},{"created":"2021-11-26T20:06:45.534307+11:00","panel_name":"Osteogenesis Imperfecta","panel_id":147,"panel_version":"0.70","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: PPIB were set to ","entity_name":"PPIB","entity_type":"gene"},{"created":"2021-11-26T20:06:22.114091+11:00","panel_name":"Osteogenesis Imperfecta","panel_id":147,"panel_version":"0.69","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: PPIB was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"PPIB","entity_type":"gene"},{"created":"2021-11-26T20:05:57.340579+11:00","panel_name":"Osteogenesis Imperfecta","panel_id":147,"panel_version":"0.68","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: PPIB: Rating: GREEN; Mode of pathogenicity: None; Publications: 19781681, 32392875; Phenotypes: Osteogenesis imperfecta, type IX, MIM# 259440; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"PPIB","entity_type":"gene"},{"created":"2021-11-26T20:05:24.030617+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9903","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PPIB as ready","entity_name":"PPIB","entity_type":"gene"},{"created":"2021-11-26T20:05:24.020435+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9903","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ppib has been classified as Green List (High Evidence).","entity_name":"PPIB","entity_type":"gene"},{"created":"2021-11-26T20:05:16.941173+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9903","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PPIB were changed from  to Osteogenesis imperfecta, type IX, MIM# 259440","entity_name":"PPIB","entity_type":"gene"}]}